RCRajya Lakshmi Chavakula

Rajya Lakshmi Chavakula

*This is an algorithmically generated author record based on publicly available information.

Rajya Lakshmi Chavakula has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Engineered cobalt-doped magnetic MOF@Ag₂O nanocomposites for adsorptive removal of polycyclic musk pollutants

    by Kumar Tarun, Pavani Peddi, M.V. Lakshmi, Ch. Rajyalakshmi, Venkateswara Anna

    Due to the increasing consumption of fossil fuels, there is a growing demand for renewable energy resources. At the same time, a significant amount of agricultural waste accumulates, including corn residues, and efficient management of this waste is a challenge. In this work, the waste biomass, which consisted of the stalks of two types of corn, was characterized and subjected to the pyrolysis process at 400°C. Physicochemical characterization of the obtained liquid fraction (bio-oil) was performed, and the obtained data were compared with literature data for liquid biofuel. The calorific value of bio-oil was above 22 MJ kg^{-1} , which indicates the good potential of waste corn biomass as an energy source. With appropriate further changes in the composition of waste, by adding materials with a higher carbon and hydrogen content, corn stalks can represent a significant energy source, with better regulation of disposal and storage of agricultural waste.

  • IoT-Based Hi-Tech Battery Charger for Modern EVs

    by V. V. Vijetha Inti, Mamatha Deenakonda, N. Bhanupriya, Rajya Lakshmi. Ch, Trpalleswari Yalla, Asapu Siva


  • Open Access

    QUALITY CONTROL ASSESSMENT OF DUTASTERIDE AND SILODOSIN IN CAPSULES AND TABLETS EMPLOYING A NOVEL DEVELOPED HPLC TECHNIQUE; EVALUATION OF STABILITIES OF DUTASTERIDE AND SILODOSIN IN ACCELERATED DEGRADATION

    by Kadali Jagadeesh, K. Ganesh Kadiyala, B. N. Suresh Varma Dendukuri, Rama Swamy Guttula, V. L. N. Balaji Gupta Tiruveedhi, Peddinti Vamsi, Rajya Lakshmi Chavakula

    Objective: The combination of dutasteride (DTRE) plus silodosin (SLDN) is used for treating acute urine retention brought upon by benign prostatic hyperplasia in men. The contents of DTRE and SLDN in capsules and tablets must be monitored for quality. In this research, a quick, selective and robust stability indicating HPLC method has been developed for concurrent assay of DTRE and SLDN in capsules and tablets. Also, the stabilities of DTRE and SLDN under several types of applied stress were determined. Methods: Analysis performed using Xterra Symmetry type column C18 (“4.6 mm x 150 mm, 5 mm” dimensions) and mobile phase having 0.1N strength, 20% volume fraction of dipotassium hydrogen phosphate and 80% volume fraction of pure form acetonitrile; PDA analysis was made at 265 nm. Stabilities of DTRE and SLDN were determined under several types of applied stress, including thermal, basic, oxidative, photo, and acid. Results: The elution times for DTRE and SLDN were 2.003 min and 3.377 min, respectively. DTRE and SLDN linear ranges were 20–120 µg/mL and 1.25–7.5 µg/mL, respectively. Method is precise with 0.2498% (DTRE) and 0.0773% (SLDN) RSD values. Method is accurate with 98.913-101.049% (DTRE) and 100.023-100.162% (SLDN) recovery values. In degradation investigation, degradant’s peaks elution times are different from the elution times of DTRE and SLDN. Thus, proved specificity and stability indicating power of the method. DTRE and SLDN were found relatively stable in thermal and were found sensitive in oxidation. In overall, SLDN found more sensitive to applied stress, including thermal, basic, oxidative, photo, and acid compared to DTRE. Conclusion: Finally, this developed analytical approach was efficaciously applied to a commercial capsule and tablet formulations containing fixed dose of DTRE and SLDN, demonstrating its usefulness for quality control and degradation investigations on DTRE and SLDN.


  • Quantification of Drospirenone- and Ethinyl Estradiol-Related Impurities in a Combined Pharmaceutical Dosage Form by a Chromatography Method With a QbD Robustness Study

    by Srinivasa Reddy Chinta, Vaishnavi Chintala, Vishnu Nandimalla, Rajyalakshmi Ch, Sasikiran Goud Ediga, Leela Prasad Kowtharapu, Naresh Kumar Katari

    Background: The estimation of drugs containing drospirenone (DRSP) and ethinyl estradiol (EE), and their related impurities, in low-dose oral contraceptive drug products is an extremely challenging target. The proposed research sought to develop and validate a stability-indicating method for quantifying drug substances and their related impurities in tablet formulation. Objective: To develop and validate a simple, specific, accurate, precise, and stability-indicating reverse-phase (RP)-HPLC method for quantification of DRSP, EE, and their impurities in accordance with International Conference on Harmonisation (ICH) guidelines. Method: The separation was achieved using an Agilent Zorbax SB C18 column (4.6 mm × 250 mm, 5 µm) with a detection wavelength of 215 nm and mobile phases A (100% acetonitrile) and B (acetonitrile–water, 1 + 3, v/v) at a flow rate of 1.3 mL/min and a column temperature of 40°C. Results: The recovery study of each impurity was conducted in the range of 24 to 72 µg/mL for DRSP-related impurities and 0.2 to 0.6 µg/mL for EE-related impurities with respect to the specification limit. A linearity study was conducted over a range of 1.5 to 90 µg/mL for DRSP and DRSP-related impurities, and 0.125 to 0.75 µg/mL for EE-related impurities. A Quality by Design (QbD) study demonstrated the method’s robustness. Conclusions: As per current guidelines, a stability-indicating method has been developed for the determination of impurities in DRSP/EE film-coated tablets. A QbD-based robustness test was performed and the method was found to be robust. Highlights: An accurate, precise, stability-indicating, gradient RP-HPLC method has been developed and validated to determine DRSP, EE, and nine related impurities in tablet formulation. A QbD technique was used to establish a robustness study.


  • Open Access

    Hydrothermal Synthesis and Micro-Structural, Optical and Luminescence Properties of Core-Shell Hetero Structure CdS/Zn3(PO4)2 Nanocomposite

    by G. Sreedevi, T. Pullarao, S.K. Khaja Muswareen, S. Suresh, P. Vijaya Sirisha, Ch. Rajyalakshmi, V. Jayalakshmi

    The hydrothermal approach was used to make an inorganic semiconducting CdS/Zn3(PO4)2 nanocomposite at a mild reaction temperature of 100 ºC. The XRD data indicate peaks that correspond to CdS hexagonal structure and Zn3(PO4)2 monoclinic-phase with good crystalline character. Surprisingly, the phase shift from α-phase of Zn3(PO4)2 to γ-phase of Zn3(PO4)2 is observed under hydrothermal conditions due to the coupling of CdS with Zn3(PO4)2, as well as internal structural alterations leading to the formation of CdS/Zn3(PO4)2 nanocomposite. Debye-Scherrer and W-H methods were used to calculate average crystallite size, lattice strain and dislocation density. The average crystal lattice is 15-25 nm in size. The hexagonal spheres aggregated on rectangular flakes, indicating core-shell heterostructure, may be seen on the surface morphology of the prepared composite. Due to the quantum size effect, the absorption peak for the composite is in the visible wavelength. It also has a low optical band gap of 2.42 eV, which makes it useful for photocatalytic and photoelectrochemical applications. FT-IR spectrum shows all the fundamental vibrational modes of CdS/Zn3(PO4)2 nanocomposite. Colour coordinate values and CCT values of the prepared composites indicate that they are used for LED applications and the photoluminescence spectrum reveals a broad, intense luminescence band in the visible region with wavelengths ranging from 510 to 518 nm, in good agreement with the absorption wavelength and the CIE diagram.


  • Open Access

    A QbD and Green Analytical Chromatography Technique for the Determination of Active Pharmaceutical Ingredient, Preservative and Antioxidant Contents in Lincosamide Antibiotic Injectable Formulation

    by Mr.LEela Prasad Kowtharapu, Naresh Kumar Katari, Dr.CHristian A. Sandoval, Mr.SIva Krishna Muchakayala, Dr.RAjyalakshmi Ch, Vijay Kumar Rekulapally

    A lincosamide antibiotic injectable formulation contains clindamycin phosphate (CMN), benzyl alcohol (BAL), and Ethylenediaminetetraacetic acid (EDTA), all the contents were qualitatively and quantitatively determined by a single green liquid chromatography method. The three components were separated with Phenomenex prodigy C8 (250 mm x 4.6 mm, 5µm) HPLC column, flow rate 1.1 mL/min, injection volume 30 µL, and column temperature 35 °C. Lambda max 240 nm was set for the detection. 0.05M, pH 4.5 sodium acetate buffer with acetonitrile in the ratio of (80:20, v/v) were used. The method was validated as per ICH guidelines and proven that the method was specific, precise, accurate, and linear. Method robustness executed by utilizing quality by design experiment and concluded method is robust. Accuracy results were found 99.6 to 100.5 for CMN, 99.8 to 100.5 for BAL, and 99.2 to 100.1 for EDTA. Precision results were obtained % RSD 1.0% for CMN, 0.8% for BAL and 0.6% for EDTA. Correlation coefficient (r2) values obtained more than 0.999 for three components. Analytical solutions are stable for 48 hrs at benchtop and refrigerator conditions. Analytical method greenness was evaluated by utilizing the GAPI, NEMI, and analytical Eco-scale tools and confirmed the method is Eco-friendly.